Standard
Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials. / Doi, Takahito; Langsted, Anne; Nordestgaard, Børge G.
I:
Journal of Internal Medicine, Bind 295, Nr. 5, 2024, s. 707-710.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
Doi, T, Langsted, A
& Nordestgaard, BG 2024, '
Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials',
Journal of Internal Medicine, bind 295, nr. 5, s. 707-710.
https://doi.org/10.1111/joim.13771APA
Doi, T., Langsted, A.
, & Nordestgaard, B. G. (2024).
Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials.
Journal of Internal Medicine,
295(5), 707-710.
https://doi.org/10.1111/joim.13771Vancouver
Doi T, Langsted A
, Nordestgaard BG.
Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials.
Journal of Internal Medicine. 2024;295(5):707-710.
https://doi.org/10.1111/joim.13771Author
Doi, Takahito ; Langsted, Anne ; Nordestgaard, Børge G. / Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials. I: Journal of Internal Medicine. 2024 ; Bind 295, Nr. 5. s. 707-710.
Bibtex
@article{95969c12e0024ef7acf9e071f6b9e84e,
title = "Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials",
keywords = "coronary disease, lipids, myocardial infarction, stroke, triglycerides-rich lipoproteins, very low-density lipoproteins",
author = "Takahito Doi and Anne Langsted and Nordestgaard, {B{\o}rge G.}",
note = "Funding Information: Capital Region of Denmark [research fund to TD], Grant Number: A7165 and A7272; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark, Japan Society for the Promotion of Science, JSPS: Postdoctoral Fellowship for Research Abroad to TD, Grant Number: 202360405. The funders had no direct role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. ",
year = "2024",
doi = "10.1111/joim.13771",
language = "English",
volume = "295",
pages = "707--710",
journal = "Journal of Internal Medicine",
issn = "0955-7873",
publisher = "Wiley-Blackwell",
number = "5",
}
RIS
TY - JOUR
T1 - Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trials
AU - Doi, Takahito
AU - Langsted, Anne
AU - Nordestgaard, Børge G.
N1 - Funding Information:
Capital Region of Denmark [research fund to TD], Grant Number: A7165 and A7272; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark, Japan Society for the Promotion of Science, JSPS: Postdoctoral Fellowship for Research Abroad to TD, Grant Number: 202360405. The funders had no direct role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
PY - 2024
Y1 - 2024
KW - coronary disease
KW - lipids
KW - myocardial infarction
KW - stroke
KW - triglycerides-rich lipoproteins
KW - very low-density lipoproteins
U2 - 10.1111/joim.13771
DO - 10.1111/joim.13771
M3 - Comment/debate
C2 - 38343109
AN - SCOPUS:85185104252
VL - 295
SP - 707
EP - 710
JO - Journal of Internal Medicine
JF - Journal of Internal Medicine
SN - 0955-7873
IS - 5
ER -
